The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
Abstract
Apigenin is a dietary flavonoid with known antioxidant and antitumor effects against several types of cancers by promoting cell death and inducing cell cycle arrest. Apigenin also regulates a variety of intracellular signal transduction pathways during apoptosis or autophagy. However, the precise mechanism underlying the anticancer effects of apigenin in liver cancer remains poorly understood. In this study, we demonstrated that apigenin has anticancer activity against hepatocellular carcinoma cells. Apigenin inhibited the cell growth and induced cell death in a dose- and time-dependent manner in HepG2 cells. We found that apigenin treatment increased the expression of LC3-II and the number of GFP-LC3 puncta. Moreover, inhibition of autophagy with 3-MA and Atg5 gene silencing strengthened apigenin-induced proliferation inhibition and apoptosis. Our data has indicated that apigenin-induced autophagy has a protective effect against cell death. Additionally, apigenin induced apoptosis and autophagy through inhibition of PI3K/Akt/mTOR pathway. Most importantly, in vivo data showed that administration of apigenin decreased tumor growth and autophagy inhibition by 3-MA significantly enhanced the anticancer effect of apigenin. Collectively, our results reveal that apigenin inhibits cell proliferation and induces autophagy via suppressing the PI3K/Akt/mTOR pathway. Our results also suggest combination of autophagy inhibitors and apigenin would be a potential chemotherapeutic strategy against hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Autophagy modulation as a potential therapeutic target for diverse diseases
Rubinsztein, D. C., Codogno, P., & Levine, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3802 · Cited by 1,437
Apigenin and cancer chemoprevention: Progress, potential and promise (Review)
Patel, D., Shukla, S., & Gupta, S. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.1.233 · Cited by 526
Blocked Autophagy Sensitizes Resistant Carcinoma Cells to Radiation Therapy
Apel, A., Herr, I., Schwarz, H., Rodemann, H. P., & Mayer, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-0562 · Cited by 523
The Roles of Therapy-Induced Autophagy and Necrosis in Cancer Treatment
Amaravadi, R. K., & Thompson, C. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1595 · Cited by 465
Therapeutic targets in cancer cell metabolism and autophagy
Cheong, H., Lu, C., Lindsten, T., & Thompson, C. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2285 · Cited by 315
Autophagy and metastasis: another double-edged sword
Kenific, C. M., Thorburn, A., & Debnath, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.10.008 · Cited by 311
ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy
Dewaele, M., Maes, H., & Agostinis, P. (2010) · Autophagy · doi:10.4161/auto.6.7.12113 · Cited by 306
Current treatment strategies for inhibiting mTOR in cancer
Chiarini, F., Evangelisti, C., McCubrey, J. A., & Martelli, A. M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.004 · Cited by 275
Chemopreventive strategies in hepatocellular carcinoma
Singh, S., Singh, P. P., Roberts, L. R., & Sanchez, W. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.143 · Cited by 273
Uberti, F., Lattuada, D., Morsanuto, V., Nava, U., Bolis, G., Vacca, G., Squarzanti, D. F., Cisari, C., & Molinari, C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2103 · Cited by 238
Apigenin inhibits tumor angiogenesis through decreasing HIF-1 and VEGF expression
Fang, J., Zhou, Q., Liu, L.-Z., Xia, C., Hu, X., Shi, X., & Jiang, B.-H. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl205 · Cited by 216
Papadimitrakopoulou, V. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31825493eb · Cited by 215
Singh, B. N., Kumar, D., Shankar, S., & Srivastava, R. K. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.007 · Cited by 209
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
Shukla, S., Bhaskaran, N., Babcook, M. A., Fu, P., MacLennan, G. T., & Gupta, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt316 · Cited by 188
Autophagy-mediated regulation of macrophages and its applications for cancer
Chen, P., Cescon, M., & Bonaldo, P. (2014) · Autophagy · doi:10.4161/auto.26927 · Cited by 181
Tseng, T., Chien, M., Lin, W., Wen, Y., Chow, J., Chen, C., Kuo, T., & Lee, W. (2017) · Environmental Toxicology · doi:10.1002/tox.22247 · Cited by 167
Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells.
Cao, X., Liu, B., Cao, W., Zhang, W., Zhang, F., Zhao, H., Meng, R., Zhang, L., Niu, R., Hao, X., et al. (2013) · Chinese Journal of Cancer Research · doi:10.3978/j.issn.1000-9604.2013.04.01 · Cited by 147
Xiong, Y., Yepuri, G., Forbiteh, M., Yu, Y., Montani, J., Yang, Z., & Ming, X. (2014) · Autophagy · doi:10.4161/15548627.2014.981789 · Cited by 144
Tsai, J.-P., Lee, C., Ying, T.-H., Lin, C., Lin, C., Hsueh, J.-T., & Hsieh, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4767 · Cited by 135
Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells
Du, Q., Hu, B., An, H., Shen, K., Xu, L., Deng, S., & Wei, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2310 · Cited by 122
Shi, M., Shiao, C.-K., Lee, Y., & Shih, Y. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0186-0 · Cited by 120
Targeting autophagy in cancer management – strategies and developments
Özpolat, B., & Benbrook, D. M. (2015) · Cancer Management and Research · doi:10.2147/cmar.s34859 · Cited by 117
Apigenin inhibits NF-κB and Snail signaling, EMT and metastasis in human hepatocellular carcinoma
Qin, Y., Zhao, D., Zhou, H., Wang, X.-H., Zhong, W., Chen, S., Gu, W., Wang, W., Zhang, C., Liu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9404 · Cited by 114
Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer
Zhou, J., Yang, J., Fan, X., Hu, S., Zhou, F., Dong, J., Zhang, S., Shang, Y., Jiang, X., Guo, H., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1136770 · Cited by 112
Self-citationDefining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer
Gonzalez-Angulo, A. M., & Blumenschein, G. R. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.11.002 · Cited by 108
McVean, M., Xiao, H., Isobe, K., & Pelling, J. C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.633 · Cited by 104
Chen, P., Yu, J., Chalmers, B., Drisko, J., Yang, J., Li, B., & Chen, Q. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834fd01f · Cited by 97
Self-citationShin, D. Y., Kim, G., Li, W., Choi, B. T., Kim, N. D., Kang, H. S., & Choi, Y. H. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.08.001 · Cited by 94
Apigenin induces ROS‐dependent apoptosis and ER stress in human endometriosis cells
Park, S., Lim, W., Bazer, F. W., & Song, G. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26054 · Cited by 86
Hu, X., Liang, J., Guo, X., Liu, L., & Guo, Y. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12333 · Cited by 70
Dross, R. V., Hong, X., Essengue, S., Fischer, S. M., & Pelling, J. C. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20281 · Cited by 67
Abu‐Yousif, A. O., Smith, K. A., Getsios, S., Green, K. J., Dross, R. V., & Pelling, J. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2763 · Cited by 62
Fu, M., Wan, F., Li, Z., & Zhang, F. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.030 · Cited by 50
Hao, H., Zhang, D., Shi, J., Wang, Y., Chen, L., Guo, Y., Ma, J., Jiang, X., & Jiang, H. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000316 · Cited by 46
Apigenin Induces the Apoptosis and Regulates MAPK Signaling Pathways in Mouse Macrophage ANA-1 Cells
Liao, Y., Shen, W., Kong, G., Houning, L., Wenhua, T., & Bo, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092007 · Cited by 42
Zhang, X., Han, W., Liu, Z., Yuan, Q., Wei, A., Du, S., Yang, X. Z., & Ruan, J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.011 · Cited by 36
Tong, X., Mirzoeva, S., Veliceasa, D., Bridgeman, B. B., Fitchev, P., Cornwell, M. L., Crawford, S. E., Pelling, J. C., & Volpert, O. V. (2014) · Oncotarget · doi:10.18632/oncotarget.2551 · Cited by 35
The anticancer effect of chaetocin is enhanced by inhibition of autophagy
Jung, H.-J., Seo, I., Casciello, F., Jacquelin, S., Lane, S., Suh, S.-I., Suh, M. ‐., Lee, J. S., & Baek, W.-K. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.15 · Cited by 34
Xu, C., Wang, Q., Feng, X., & Bo, Y. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.10.010 · Cited by 32
Tong, X., & Pelling, J. C. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20460 · Cited by 28
Cited by
Tewari, D., Patni, P., Bishayee, A., Sah, A. N., & Bishayee, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.008 · Cited by 642
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents
Hashem, S., Ali, T. A., Akhtar, S., Nisar, S., Sageena, G., Ali, S., Al-Mannai, S., Therachiyil, L., Mir, R., Elfaki, I., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113054 · Cited by 377
Role of Phytochemicals in Cancer Chemoprevention: Insights
George, B. P., Chandran, R., & Abrahamse, H. (2021) · Antioxidants · doi:10.3390/antiox10091455 · Cited by 295
The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases
Wang, H., Liu, Y., Wang, D., Xu, Y., Dong, R., Yang, Y., Lv, Q., Chen, X., & Zhang, Z. (2019) · Cells · doi:10.3390/cells8121597 · Cited by 279
Bioactive potential of beetroot (Beta vulgaris)
Punia Bangar, S., Sharma, N., Sanwal, N., Lorenzo, J. M., & Sahu, J. K. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111556 · Cited by 92
Metadata
- Authors
- Yang, J., Pi, C., & Wang, G.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 103
- Pages
- 699-707
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2802723445
- Cited by
- 450
- References
- 42
- FWCI
- 17.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.